Terms: = Leukemia AND MAF, MGC71685, 4094, ENSG00000178573 AND Prognosis
5 results:
1. GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate.
Ríos I; López-Navarro B; Torres-Torresano M; Soler Palacios B; Simón-Fuentes M; Domínguez-Soto Á; Muller IB; Jansen G; Corbí ÁL; Puig-Kröger A
J Innate Immun; 2023; 15(1):283-296. PubMed ID: 36380627
[TBL] [Abstract] [Full Text] [Related]
2. C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse.
Yang LX; Zhang CT; Yang MY; Zhang XH; Liu HC; Luo CH; Jiang Y; Wang ZM; Yang ZY; Shi ZP; Yang YC; Wei RQ; Zhou L; Mi J; Zhou AW; Yao ZR; Xia L; Yan JS; Lu Y
Blood; 2023 Feb; 141(7):766-786. PubMed ID: 36322939
[TBL] [Abstract] [Full Text] [Related]
3. Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.
Farre L; Sanz G; Ruiz-Xivillé N; Castro de Moura M; Martin-Tejera JF; Gonçalves-Ribeiro S; Martinez-Iniesta M; Calaf M; Luis Mosquera J; Martín-Subero JI; Granada I; Esteller M; Domingo-Domenech E; Climent F; Villanueva A; Sureda A
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 33988237
[TBL] [Abstract] [Full Text] [Related]
4. Molecular pathogenesis and a consequent classification of multiple myeloma.
Bergsagel PL; Kuehl WM
J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
[TBL] [Abstract] [Full Text] [Related]
5. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Leukemia; 1993 Mar; 7(3):392-7. PubMed ID: 8445945
[TBL] [Abstract] [Full Text] [Related]
